Skopos Labs, Inc. Ptc Therapeutics, Inc. Transaction History
Skopos Labs, Inc.
- $330 Million
- Q4 2024
A detailed history of Skopos Labs, Inc. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 18 shares of PTCT stock, worth $789. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18Holding current value
$789% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PTCT
# of Institutions
221Shares Held
78MCall Options Held
144KPut Options Held
58.7K-
Vanguard Group Inc Valley Forge, PA9.13MShares$400 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$346 Million0.05% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$341 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.39MShares$324 Million4.37% of portfolio
-
Armistice Capital, LLC New York, NY7.23MShares$317 Million4.46% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.14B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...